CAN Stock Overview

Engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. More details

CAN fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

Risk Analysis

Earnings have declined by 22.8% per year over past 5 years

Does not have a meaningful market cap (A$10M)

Shareholders have been substantially diluted in the past year

Volatile share price over the past 3 months compared to the Australian market

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Cann Group Limited Competitors

Percheron Therapeutics

ASX:PER

AU$9.8m

Acrux

ASX:ACR

AU$9.4m

Althea Group Holdings

ASX:AGH

AU$11.5m

Epsilon Healthcare

ASX:EPN

AU$7.2m

Price History & Performance

Summary of share price highs, lows and changes for Cann Group
Historical stock prices
Current Share Price	AU$0.016
52 Week High	AU$0.13
52 Week Low	AU$0.015
Beta	1.33
1 Month Change	-40.74%
3 Month Change	-48.39%
1 Year Change	n/a
3 Year Change	-94.67%
5 Year Change	-98.48%
Change since IPO	-97.54%

Recent updates

Shareholder Returns

	CAN	AU Pharmaceuticals	AU Market
7D	-3.0%	7.9%	3.5%
1Y	n/a	-17.6%	5.9%

Return vs Industry: Insufficient data to determine how CAN performed against the Australian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how CAN performed against the Australian Market.

Price Volatility

Is CAN's price volatile compared to industry and market?
CAN volatility
CAN Average Weekly Movement	13.0%
Pharmaceuticals Industry Average Movement	12.1%
Market Average Movement	9.4%
10% most volatile stocks in AU Market	16.6%
10% least volatile stocks in AU Market	4.1%

Stable Share Price: CAN's share price has been volatile over the past 3 months compared to the Australian market.

Volatility Over Time: CAN's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Jenni Pilcher	www.canngrouplimited.com

Cann Group Limited, together with its subsidiaries, engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe. It also licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.

Cann Group Limited Fundamentals Summary

How do Cann Group's earnings and revenue compare to its market cap?
CAN fundamental statistics
Market cap	AU$9.65m
Earnings (TTM)	-AU$47.60m
Revenue (TTM)	AU$15.51m

0.7x

P/S Ratio

-0.2x

P/E Ratio

Is CAN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CAN income statement (TTM)
Revenue	AU$15.51m
Cost of Revenue	AU$10.58m
Gross Profit	AU$4.93m
Other Expenses	AU$52.53m
Earnings	-AU$47.60m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.079
Gross Margin	31.76%
Net Profit Margin	-306.99%
Debt/Equity Ratio	1,136.9%

How did CAN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/05 07:40
End of Day Share Price	2025/05/02 00:00
Earnings	2024/12/31
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cann Group Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Cameron Bell	Canaccord Genuity
Paul Jensz	PAC Partners Securities Pty. Ltd.

CAN Stock Overview

Risk Analysis

Cann Group Limited Competitors

ASX:PER

AU$9.8m

ASX:ACR

AU$9.4m

ASX:AGH

AU$11.5m

ASX:EPN

AU$7.2m

Price History & Performance

Recent News & Updates

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.711902 million.

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.711902 million.

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.105 million.

Less than half of directors are independent

Less than half of directors are independent

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 2.255994 million.

Recent updates

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 0.711902 million.

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.711902 million.

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.105 million.

Less than half of directors are independent

Less than half of directors are independent

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 2.255994 million.

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.252486 million.

Cann Group Limited, Annual General Meeting, Oct 28, 2024

Full year 2024 earnings released: AU$0.12 loss per share (vs AU$0.091 loss in FY 2023)

Cann Group Limited to Report Fiscal Year 2024 Results on Aug 30, 2024

Cann Group Limited Appoints Jenni Pilcher as Managing Director

Less than half of directors are independent

New major risk - Financial position

Cann Group Limited Appoints Tony Di Pietro as Joint Company Secretary of Head of Legal and Regulatory Affairs

Cann Group Limited Announces Resignation of Deborah Ambrosini as Chief Financial Officer, Effective December 22, 2023

Cann Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.3756 million.

Cann Group Limited, Annual General Meeting, Oct 26, 2023

Full year 2023 earnings released: AU$0.091 loss per share (vs AU$0.079 loss in FY 2022)

New minor risk - Financial data availability

Cann Group Limited has completed a Follow-on Equity Offering in the amount of AUD 11.658446 million.

Cann Group Limited Provides Revenue Guidance for the Year Ended June 30, 2023

New minor risk - Share price stability

First half 2023 earnings released: AU$0.053 loss per share (vs AU$0.028 loss in 1H 2022)

Cann Group Limited Announces Preliminary Results from Their Phase 3 Clinical Trail

Cann Group Limited Announces Chief Executive Officer Changes

Less than half of directors are independent

Full year 2022 earnings released: AU$0.079 loss per share (vs AU$0.098 loss in FY 2021)

Less than half of directors are independent

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer Greg Bullock has left the company

Full year 2021 earnings released: AU$0.097 loss per share (vs AU$0.12 loss in FY 2020)

First half 2021 earnings released: AU$0.05 loss per share (vs AU$0.06 loss in 1H 2020)

New 90-day high: AU$0.76

New 90-day high: AU$0.49

Deputy Chairman recently bought AU$55k worth of stock

New 90-day low: AU$0.39

Cann Group Limited(ASX:CAN) dropped from S&P/ASX All Ordinaries Index

Shareholder Returns

Price Volatility

About the Company

Cann Group Limited Fundamentals Summary

0.7x

-0.2x

Earnings & Revenue

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources